Akari Therapeutics, Plc (AKTX)
NASDAQ·Healthcare·Biotechnology
$5.72
+2.14%
Mkt Cap $4.49K
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q2 2026 Apr 7, 2026 | — | — | — | -$1.80 | -$2.99 | -66.11% | — | — |
| Q4 2025 Nov 13, 2025 | — | — | — | -$0.04 | -$0.10 | -150.00% | — | — |
| Q3 2025 Aug 13, 2025 | — | — | — | -$0.09 | -$0.06 | +33.33% | — | — |
| Q2 2025 May 14, 2025 | — | — | — | — | -$0.14 | — | — | — |
| Q2 2025 Apr 14, 2025 | — | — | — | -$1.00 | -$0.17 | +83.00% | — | — |
| Q4 2024 Nov 19, 2024 | — | — | — | -$0.60 | -$9.60 | -1500.00% | — | — |
| Q3 2024 Aug 19, 2024 | — | — | — | -$1.00 | -$3.20 | -220.00% | — | — |
| Q2 2024 May 15, 2024 | — | — | — | -$1.00 | -$3.20 | -220.00% | — | — |
| Q1 2024 Mar 29, 2024 | — | — | — | — | -$2.40 | — | — | — |
| Q4 2023 Oct 3, 2023 | — | — | — | -$0.60 | -$2.40 | -300.00% | — | — |
| Q3 2023 Sep 26, 2023 | — | — | — | -$1.00 | $2.00 | +300.00% | — | — |
| Q3 2023 Jul 19, 2023 | — | — | — | -$0.07 | -$0.10 | -42.86% | — | — |
| Q1 2023 Mar 27, 2023 | — | — | — | — | -$4.00 | — | — | — |
| Q1 2023 Mar 9, 2023 | — | — | — | — | -$0.00 | — | — | — |
| Q3 2022 Sep 27, 2022 | — | — | — | — | -$2.00 | — | — | — |
| Q2 2022 May 16, 2022 | — | — | — | — | -$2.40 | — | — | — |
| Q4 2021 Dec 3, 2021 | — | — | — | — | -$0.60 | — | — | — |
| Q3 2021 Sep 22, 2021 | — | — | — | — | -$2.20 | — | — | — |
| Q2 2021 Apr 20, 2021 | — | — | — | — | -$4.40 | — | — | — |
| Q4 2020 Dec 11, 2020 | — | — | — | — | $0.80 | — | — | — |